William Lotter
机构：Dana-Farber Cancer Institute
发表论文 2 篇
代表论文
- Tumor mutational burden as a predictor of immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors: a Brief Report (2026 · Journal of Thoracic Oncology)
- OA01.04: Tumor Mutational Burden as a Predictor of Immune-Related Adverse Events in Patients With Advanced Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors (2026 · Journal of Thoracic Oncology)